Related Experiment Video
Updated: May 9, 2026

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
Conjugation process development and scale-up
Bernhard Stump1, Jessica Steinmann
1Bioconjugates R&D, Lonza Ltd, Visp, Switzerland.
Abstract:
Manufacturing highly potent antibody-drug conjugates (ADCs) is a demanding task-combining conventional organic synthesis with biotechnological manufacturing. Hence a series of new and unique engineering and chemistry challenges have to be addressed to support clinical trials and commercial manufacturing. These include the development of reliable processes leading to uniform product properties, as well as establishment of ADC-specific analytical methods and safe strategies for handling cytotoxic compounds. This review focuses on process development and scale-up for the production of ADCs and highlights the most important features in such a process.
More Related Videos
Related Concept Videos
Scale-Up Processes
Upstream Processing
Phase II Conjugation Reactions: Overview
Phase II Reactions: Miscellaneous Conjugation Reactions
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
Bioreactor Controls-III
Drug Metabolism: Phase II Reactions

